share_log

Cynata Therapeutics Ltd: Phase 2 Trial of CYP-001 in aGvHD Approved in Turkey

Dec 7, 2023 06:39
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.